Angus, United Kingdom

Neil McIntyre

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Cyclacel Limited. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Neil McIntyre. Retrieved from https://idiyas.com/inventor/neil-mcintyre

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Neil McIntyre: Innovator in Pharmaceutical Compounds

Introduction

Neil McIntyre is a notable inventor based in Angus, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit protein kinases. His work is crucial for advancing treatments for various medical conditions.

Latest Patents

Neil McIntyre holds a patent for "Thiazolo-, oxazalo and imidazolo-quinazoline compounds capable of inhibiting protein kinases." This patent describes a compound of formula 1, which includes various chemical structures and groups that can be utilized in pharmaceutical compositions. These compounds are aimed at treating proliferative disorders, viral disorders, CNS disorders, diabetes, stroke, and cardiovascular disorders.

Career Highlights

Neil McIntyre is associated with Cyclacel Limited, a company focused on developing innovative cancer therapies. His work at Cyclacel has positioned him as a key player in the pharmaceutical industry, contributing to the advancement of therapeutic solutions.

Collaborations

Neil has collaborated with notable colleagues, including Campbell McInnes and Mark Thomas. These partnerships have enhanced the research and development efforts within his field.

Conclusion

Neil McIntyre's innovative work in pharmaceutical compounds demonstrates his commitment to improving healthcare through scientific advancements. His contributions are vital for the ongoing development of effective treatments for various diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…